Balchem Corporation (BCPC)
- Previous Close
138.50 - Open
138.70 - Bid 139.02 x 100
- Ask 139.72 x 100
- Day's Range
138.70 - 139.72 - 52 Week Range
110.74 - 159.52 - Volume
17,771 - Avg. Volume
100,667 - Market Cap (intraday)
4.504B - Beta (5Y Monthly) 0.70
- PE Ratio (TTM)
41.67 - EPS (TTM)
3.35 - Earnings Date May 3, 2024
- Forward Dividend & Yield 0.79 (0.57%)
- Ex-Dividend Date Dec 26, 2023
- 1y Target Est
154.33
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
www.balchem.com1,302
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BCPC
Performance Overview: BCPC
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BCPC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BCPC
Valuation Measures
Market Cap
4.47B
Enterprise Value
4.73B
Trailing P/E
41.34
Forward P/E
33.78
PEG Ratio (5yr expected)
3.07
Price/Sales (ttm)
4.87
Price/Book (mrq)
4.24
Enterprise Value/Revenue
5.13
Enterprise Value/EBITDA
22.04
Financial Highlights
Profitability and Income Statement
Profit Margin
11.77%
Return on Assets (ttm)
6.09%
Return on Equity (ttm)
10.90%
Revenue (ttm)
922.44M
Net Income Avi to Common (ttm)
108.54M
Diluted EPS (ttm)
3.35
Balance Sheet and Cash Flow
Total Cash (mrq)
64.45M
Total Debt/Equity (mrq)
31.34%
Levered Free Cash Flow (ttm)
142.6M
Research Analysis: BCPC
Company Insights: BCPC
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: BCPC
BCPC: Rating increased to a HOLD
BALCHEM CORP has an Investment Rating of HOLD; a target price of $131.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetBCPC: Lowering target price to $131.00
BALCHEM CORP has an Investment Rating of SELL; a target price of $131.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetBCPC: Raising target price to $137.00
BALCHEM CORP has an Investment Rating of SELL; a target price of $137.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetBCPC: Lowering target price to $136.00
BALCHEM CORP has an Investment Rating of SELL; a target price of $136.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target